Abstract
Lipohypertrophies frequently occur during insulin therapy. They alter insulin absorption, causing higher insulin requirements (and costs), fluctuating blood glucose and episodes of unpredictable hypoglycemia. Screening is mandatory, as well as assessment of their actual size. Counseling recommending regular changes of the injection sites ("rotating") is important to prevent LH.
K E Y W O R D S
insulin injection, insulin-dependent diabetes mellitus, lipohypertrophy Figure 1 ) compatible with LH. Because of weight loss (BMI 17.3 kg/m 2 ), a computed tomography of the abdomen was performed. Contrastingly to the visible findings, a region compatible with LH of almost 18 cm in the transverse extent was identified (Figure 2 ). Insulin therapy may cause LH due to lipogenic action and/or injection-related tissue trauma with repeated administration in the same site. 1 The prevalence of LH is reported at 37%. 2 Injection into them is less painful.
A problem is the loss of insulin effectiveness leading to higher insulin requirement (and costs) with fluctuating blood glucose concentrations and occasional episodes of unpredictable hypoglycemia. Counseling is important in LH prevention by educating patients about rotating the injection sites. Our patient was advised to do so and reduce the insulin dose by 10%. Three months later, her glycemic control had improved with an Hba1c of 7.3 (56 mmol/mol).
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